PRKCI promotes immune suppression in ovarian cancer.

PRKCI promotes immune suppression in ovarian cancer.

Genes & development (2017-07-13)

Sharmistha Sarkar, Christopher A Bristow, Prasenjit Dey, Kunal Rai, Ruth Perets, Alejandra Ramirez-Cardenas, Shruti Malasi, Emmet Huang-Hobbs, Monika Haemmerle, Sherry Y Wu, Michael McGuire, Alexei Protopopov, Shan Jiang, Joyce F Liu, Michelle S Hirsch, Qing Chang, Alexander J Lazar, Anil K Sood, Ronny Drapkin, Ronald DePinho, Giulio Draetta, Lynda Chin

PMID28698296

RESUMO

A key feature of high-grade serous ovarian carcinoma (HGSOC) is frequent amplification of the 3q26 locus harboring

MATERIAIS

Número do produto

Marca

Descrição do produto

A3854

Sigma-Aldrich

Antiβ-actina monoclonal, clone AC-15, purified from hybridoma cell culture

T8300

Sigma-Aldrich

Anti-Tumor Necrosis Factor-α antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution

HPA026574

Sigma-Aldrich

Anti-PRKCI antibody produced in rabbit, affinity isolated antibody, buffered aqueous glycerol solution